Related Experiment Videos
Heart failure associated with high plasma 10-hydroxynortriptyline levels.
The American Journal of Psychiatry
|March 1, 1984
Summary
A patient experienced heart failure due to high levels of 10-hydroxynortriptyline, an antidepressant metabolite. Further research is needed to understand antidepressant metabolite contributions to drug effects.
Area of Science:
- Pharmacology
- Clinical Toxicology
Background:
- Antidepressant medications are widely prescribed.
- Active metabolites of antidepressants can influence drug efficacy and toxicity.
- Individual patient responses to antidepressants can vary significantly.
Observation:
- A case study detailing a patient who developed congestive heart failure.
- This patient exhibited elevated plasma concentrations of 10-hydroxynortriptyline.
Findings:
- High plasma levels of the active metabolite 10-hydroxynortriptyline were observed in a patient with congestive heart failure.
- This suggests a potential link between this specific metabolite and adverse cardiovascular events.
Implications:
- Highlights the importance of monitoring active metabolite levels in patients experiencing adverse drug reactions.
- Underscores the need for further investigation into the role of antidepressant metabolites in both toxic and therapeutic outcomes.
- Informs clinical practice regarding the potential cardiovascular risks associated with certain antidepressant metabolites.